Zhang et al(28) found that circulating B7-H3 in serumis a highly sensitive biomarker for non-small cell lung cancer (NSCLC) and increasedcirculating B7-H3 suggests a poor clinical prognosis for NSCLC patients. The gene discussed is CD276; the disease is non-small cell lung carcinoma.